Skip to main navigation Skip to search Skip to main content

Erratum: Molecular Biomarkers of Response to PD-1/PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer (Bladder Cancer (2020) 6: 4 (559-559) DOI: 10.3233/BLC-200013)

  • Megan M. Tu
  • , Terry L. Ng
  • , Florus C. De Jong
  • , Tahlita C.M. Zuiverloon
  • , Francesco G.T. Fazzari
  • , Dan Theodorescu

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

BLC-200013 is an erratum of BLC-190218. In the funding section on page 141 of BLC-190218, the authors have reported no sources of funding related to this article. However, this is incorrect and the funding details should be specified in the funding section with the following text: This work was supported in part by NCI/NIH grants CA143971 and CA075115 to D.T. The funding details in the erratum BLC-200013 contained the wrong grant number. As such, the updated funding section of this article is provided below. FUNDING This work was supported in part by NCI/NIH grants CA143971 and CA075115 to D.T.

Original languageEnglish (US)
Pages (from-to)109
Number of pages1
JournalBladder Cancer
Volume7
Issue number1
DOIs
StatePublished - 2021

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint

Dive into the research topics of 'Erratum: Molecular Biomarkers of Response to PD-1/PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer (Bladder Cancer (2020) 6: 4 (559-559) DOI: 10.3233/BLC-200013)'. Together they form a unique fingerprint.

Cite this